Marpai, Inc.
Close on Oct 19, 2026
- Market cap
- $82.24M
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q3 FY2025 Ended Sep 30, 2025 | Nov 12, 2025 | During market hours | $4.04M | $-0.20 | – |
| Q2 FY2025 Ended Jun 30, 2025 | Aug 13, 2025 | During market hours | $4.70M | $-0.28 | – |
| Q1 FY2025 Ended Mar 31, 2025 | May 14, 2025 | During market hours | $5.40M | $-0.21 | – |
| Q4 FY2024 Ended Dec 31, 2024 | Mar 27, 2025 | During market hours | $6.60M | $-0.08 | – |
| Q3 FY2024 Ended Sep 30, 2024 | Nov 12, 2024 | Before market open | $7.00M | $-0.30 | – |
| Q2 FY2024 Ended Jun 30, 2024 | Aug 7, 2024 | During market hours | $7.20M | $-1.23 | – |
| Q1 FY2024 Ended Mar 31, 2024 | May 9, 2024 | During market hours | $7.40M | $-0.46 | – |
| Q4 FY2023 Ended Dec 31, 2023 | Mar 6, 2024 | During market hours | $8.70M | – | – |
| Q3 FY2023 Ended Sep 30, 2023 | Nov 13, 2023 | During market hours | – | – | – |
| Q2 FY2023 Ended Jun 30, 2023 | Aug 3, 2023 | Before market open | – | – | – |
| Q1 FY2023 Ended Mar 31, 2023 | May 10, 2023 | During market hours | – | – | – |
| Q4 FY2022 Ended Dec 31, 2022 | Mar 29, 2023 | During market hours | – | – | – |
Press releases
Announcements Marpai filed with the SEC
PRESS RELEASE, TITLED "MARPAI. ANNOUNCES $12 MILLION PRIVATE PLACEMENT LED BY MITCHELL COMPANIES."
Material agreement · Unregistered share sale · Charter or bylaw amendment · Other events · EX-99.1 to Form 8-K
Marpai Inc. Announces Debt Restructuring Agreements with JGB
Material agreement · Other events · EX-99.1 to Form 8-K
PRESS RELEASE OF MARPAI, INC. DATED NOVEMBER 12, 2025
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE OF MARPAI, INC. DATED AUGUST 13, 2025
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE OF MARPAI, INC. DATED MAY 14, 2025
Results of operations · EX-99.1 to Form 8-K
dallas scrip as chief operating officer
Executive or director change · Other events · EX-99.1 to Form 8-K
PRESS RELEASE OF MARPAI, INC. DATED MARCH 26, 2025
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE DATED JANUARY 6, 2025, TITLED: "MARPAI ANNOUNCES SECOND TRANCHE OF NON-DILUTIVE GROWTH FUNDING WITH $5 MILLION FROM JGB"
Material agreement · New financial obligation · Unregistered share sale · Other events · EX-99.1 to Form 8-K
PRESS RELEASE DATED DECEMBER 5, 2024, TITLED: "MARPAI, INC. ANNOUNCES PRICING OF $700,000 PRIVATE PLACEMENT."
Material agreement · Unregistered share sale · Other events · EX-99.1 to Form 8-K
PRESS RELEASE OF MARPAI, INC. DATED NOVEMBER 11, 2024
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE OF MARPAI, INC. DATED AUGUST 7, 2024
Results of operations · EX-99.1 to Form 8-K
MARPAI announces withdrawal from nasdaq HEARINGS process and will transition Trading to the otcQX Market
Listing notice · Regulation FD disclosure · EX-99.1 to Form 8-K
MARPAI reports FIRST QUARTER 2024 financial results
Results of operations · EX-99.1 to Form 8-K
MARPAI reports FOURTH QUARTER AND FULL YEAR 2023 financial results
Results of operations · EX-99.1 to Form 8-K
nasdaq panel grants marpai’s request for extension to comply with continued listing requirements
Other events · EX-99.1 to Form 8-K
MARPAI ANNOUNCES PRELIMINARY UNAUDITED FINANCIAL RESULTS FOR FOURTH QUARTER AND FULL YEAR 2023
Results of operations · EX-99.1 to Form 8-K/A
MARPAI ANNOUNCES PRELIMINARY UNAUDITED FINANCIAL RESULTS FOR FOURTH QUARTER AND FULL YEAR 2023
Other events · EX-99.1 to Form 8-K
MARPAI ANNOUNCES “Off-cycle” new client agreement
Other events · EX-99.1 to Form 8-K
MARPAI ANNOUNCES KEY FINANCIAL AGREEMENTS
Material agreement · Other events · EX-99.1 to Form 8-K
MARPAI HIRES JOHN POWERS AS PRESIDENT
Executive or director change · Other events · EX-99.1 to Form 8-K
MARPAI, INC. ANNOUNCES APPOINTMENT OF TWO NEW INDEPENDENT DIRECTORS
Executive or director change · Other events · EX-99.1 to Form 8-K
MARPAI, INC. REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID PRICE COMPLIANCE
Other events · EX-99.1 to Form 8-K
| MarpaiHealth.com (NASDAQ: MRAI) Investor Webcast November 2023 EXH 99.1
Regulation FD disclosure · EX-99.1 to Form 8-K
MARPAI, INC. REPORTS Third QUARTER 2023 RESULTS
Results of operations · EX-99.1 to Form 8-K
Marpai Names Damien Lamendola as Chief Executive Officer to Drive the Next Phase of its Growth
Executive or director change · Other events · EX-99.1 to Form 8-K
MARPAI, INC. REPORTS SECOND QUARTER 2023 RESULTS
Results of operations · EX-99.1 to Form 8-K
Marpai Confirms Revenue Guidance for Q2 2023 of $9.5 Million to $9.8 Million
Results of operations · Regulation FD disclosure · EX-99.1 to Form 8-K
Marpai Announces Reverse Stock Split
Charter or bylaw amendment · Other events · EX-99.1 to Form 8-K
Marpai Launches Marpai Connect Platform to Predict and Help Modify Risk in Healthcare
Other events · EX-99.1 to Form 8-K
MARPAI, INC. REPORTS FIRST QUARTER 2023 RESULTS
Results of operations · EX-99 to Form 8-K
Marpai, Inc. Announces Proposed Public Offering of Common Stock
Material agreement · Other events · EX-99 to Form 8-K
Marpai, Inc. Announces Pricing of Public Offering
Material agreement · Other events · EX-99#2 to Form 8-K
MARPAI, INC. REPORTS THE Fourth QUARTER and YEAR END 2022 RESULTS
Results of operations · EX-99 to Form 8-K
Marpai Hires Gonen Antebi as Chief Operating Officer
Executive or director change · Other events · EX-99.1 to Form 8-K
| MarpaiHealth.com (NASDAQ: MRAI) Company Presentation February 2023 Exhibit 99.1
Executive or director change · Regulation FD disclosure · EX-99.1 to Form 8-K
December 2022 Company Presentation | MarpaiHealth.com (NASDAQ: MRAI) Exhibit 99.1
Regulation FD disclosure · EX-99.1 to Form 8-K
MARPAI, INC. REPORTS THIRD QUARTER 2022 RESULTS
Results of operations · EX-99.1 to Form 8-K
Marpai Announces Closing of the Acquisition of Maestro Health
Acquisition or disposition completed · Other events · EX-99.1 to Form 8-K
October 2022 | MarpaiHealth.com (NASDAQ: MRAI) Company Presentation Exhibit 99.1
Regulation FD disclosure · EX-99.1 to Form 8-K
Launches MarpaiRx Pharmacy Benefit Management Solution to Decrease Prescription Costs
Other events · EX-99.1 to Form 8-K